Tabla 1: Escalas de mortalidad y progresiĆ³n de COVID-19 al ingreso de los pacientes. |
|||||||
SAPS III |
|||||||
Puntaje |
5 a 6 |
9 a 10 |
11 a 12 |
13 a 14 |
19 a 20 |
> 21 |
|
Pacientes, n (%) |
5 (20) |
1 (4) |
2 (8) |
1 (4) |
2 (8) |
14 (56) |
|
Mortalidad, % |
10.7 |
19.4 |
24.5 |
30 |
50 |
81.1 |
|
APACHE II |
|||||||
Puntaje |
0 a 5 |
6 a 10 |
11 a 15 |
16 a 20 |
21 a 25 |
26 a 30 |
> 31 |
Pacientes, n (%) |
7 (28) |
8 (32) |
2 (8) |
2 (8) |
0 |
2 (8) |
4 (16) |
Mortalidad, % |
2.3 |
4.3 |
8.6 |
16.4 |
28.6 |
56.4 |
70 |
SOFA |
|||||||
Puntaje |
0 a 1 |
2 a 3 |
4 a 5 |
6 a 7 |
12 a 14 |
> 14 |
|
Pacientes, n (%) |
5 (20) |
14 (56) |
3 (12) |
1 (4) |
1 (4) |
1 (4) |
|
Mortalidad, % |
0 |
6.4 |
20.2 |
21.5 |
95.2 |
95.2 |
|
CALL-score |
|||||||
Puntaje |
4 a 6 |
7 a 9 |
10 a 13 |
|
|
|
|
Pacientes, n (%) |
10 (40) |
6 (24) |
9 (36) |
|
|
|
|
ProgresiĆ³n de COVID-19, % |
0 |
10 a 40 |
50 |
|
|
|
|
SAPS = Simplified Acute Physiology Score; APACHE = Acute Physiology and Chronic Health Evaluation; SOFA = Sequential Organ Failure Assessment; CALL-score = Comorbidity, Age, Lymphocyte y LDH. |